Formoterol: Difference between revisions
From Proteopedia
Jump to navigationJump to search
New page: <StructureSection load='1stp' size='340' side='right' caption='Caption for this structure' scene=''> Formoterol, also known as eformoterol, is a long-acting β2 agonist (LABA) used as a br... |
Michal Harel (talk | contribs) No edit summary |
||
| (7 intermediate revisions by one other user not shown) | |||
| Line 1: | Line 1: | ||
<StructureSection load=' | <StructureSection load='' size='340' side='right' caption='Formoterol' scene='96/963800/Cv/1'> | ||
Formoterol, also known as eformoterol, is a long-acting β2 agonist (LABA) used as a bronchodilator in the management of asthma and chronic obstructive pulmonary disease (COPD). Formoterol has an extended duration of action (up to 12 h) compared to short-acting β2 agonists such as salbutamol (albuterol), which are effective for 4 h to 6 h. Formoterol has a relatively rapid onset of action compared to other LABAs, and is effective within 2-3 minutes. See also [https://en.wikipedia.org/wiki/Formoterol]. | Formoterol, also known as eformoterol, is a long-acting β2 agonist (LABA) used as a bronchodilator in the management of asthma and chronic obstructive pulmonary disease (COPD). Formoterol has an extended duration of action (up to 12 h) compared to short-acting β2 agonists such as [[salbutamol]] (albuterol), which are effective for 4 h to 6 h. Formoterol has a relatively rapid onset of action compared to other LABAs, and is effective within 2-3 minutes. See also [https://en.wikipedia.org/wiki/Formoterol]. | ||
<scene name='96/963800/Overall/1'>Adrenoceptor with bound agonist formoterol</scene> ([[6tko]]). | |||
<scene name='96/963800/Surfacecavity/2'>Ligand binding cavity</scene>. | |||
<scene name='96/963800/Binding_site/2'>Formoterol binding site</scene>. | |||
</StructureSection> | </StructureSection> | ||
== References == | == References == | ||
<references/> | <references/> | ||
